Walleye Trading LLC Macrogenics Inc Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.34 - $6.98 $48,710 - $101,796	14,584 New	14,584 $97,000
Q2 2022 Aug 08, 2022	SELL	$2.25 - $9.99 $30,519 - $135,504	-13,564 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $110,139 - $229,231	13,564 New	13,564 $119,000
Q3 2017 Nov 14, 2017	SELL	$15.52 - $18.94 $72,944 - $89,018	-4,700 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	4,700	4,700 $82,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.